Mark McDonough - CEO, Cyrex Labs - Early Detection & Monitoring Of Complex Immune Conditions

Mark McDonough is the CEO of Cyrex Labs ( https://www.cyrexlabs.com/ ), a clinical immunology laboratory specializing in functional immunology and autoimmunity testing.

Cyrex offers multi-tissue antibody testing for the early detection and monitoring of today’s complex autoimmune conditions and develops innovative arrays through continuous collaboration with leading experts in medical research and clinical practice.

Mark is a global technology business executive with 30 years of experience, and his personal mission is to impact change in the field of healthcare in a compassionate yet resolute manner, leading by example.

Prior to Cyrex, Mark served in several private and public company CEO roles including PierianDx and CombiMatrix, a publicly held molecular diagnostics company performing DNA-based testing services for reproductive health, oncology, and developmental disorders.

Earlier in his career, Mark served in various sales leadership roles at high growth diagnostic companies to include Ventana Medical Systems (acquired by Roche) and US LABS (acquired by LabCorp).

Mark is married with three children and is a proud former Naval Officer having served as a Navigator and Communications Officer on the USS FLETCHER (DD 992).

#MarkMcDonough #CyrexLabs #ClinicalImmunology #FunctionalImmunology #Autoimmunity #AristoVojdani #FoodAssociatedAutoimmunities #Neuroimmunity #BrainGutConnection #LifestyleMedicine #Antigenic #Inflammation #MolecularMimicry #ImmuneReactivity #PathogenAssociatedImmuneReactivity #MultipleChemicalSensitivities #MicrobialTransglutaminase #CeliacDisease #NonCeliacGlutenSensitivity #CrohnsDisease #Neuroautoimmunity #Neurodegeneration #BloodBrainBarrier #ProgressPotentialAndPossibilities #IraPastor #Podcast #Podcaster #Podcasting #ViralPodcast #STEM #Innovation #Science #Technology #Research